Sequent Scientific
PE is negative at -42
THE CARLYLE GROUP ACQUIRES A MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED
Shares of Sequent Scientific soared over 9 percent in early trade on September 15 after the company's board approved the sale of its API (Active Pharmaceutical Ingredient) facility in Thane
Sequent Scientific (NSE:SEQUENT) delivers shareholders decent 8.8% CAGR over 5 years
Sequent Scientific shares jump 15% after terminating Tineta Pharma's proposed acquisition
mutual funds have increased stake from 0.25% to 1%
DII also increasing stake significantly
stock has come out of accumulation Phase!!!
THE CARLYLE GROUP ACQUIRES A MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED
Shares of Sequent Scientific soared over 9 percent in early trade on September 15 after the company's board approved the sale of its API (Active Pharmaceutical Ingredient) facility in Thane
Sequent Scientific (NSE:SEQUENT) delivers shareholders decent 8.8% CAGR over 5 years
Sequent Scientific shares jump 15% after terminating Tineta Pharma's proposed acquisition
mutual funds have increased stake from 0.25% to 1%
DII also increasing stake significantly
stock has come out of accumulation Phase!!!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.